ラテックス・グローブからの空気中の抗原.

Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.

ESMO gastrointestinal oncology·2026

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

ESMO gastrointestinal oncology·2026

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

ESMO real world data and digital oncology·2026

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

ESMO open·2025

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.

ESMO open·2022

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.

ESMO open·2021

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Interchromophoric excitonic coupling controls phosphorescence in thermomorphs of a carbazole dimer.

Chemical communications (Cambridge, England)·2026

Glycogen-dependent demixing of frog egg cytoplasm at increased crowding.

Biophysical journal·2026

Preferential formation of Nω-(carboxyethyl)arginine from methylglyoxal and its accumulation in human lens proteins.

Journal of biochemistry·2026

Revisiting the spectroscopic role of the s-cis rotamer of 1,6-diphenyl-1,3,5-hexatriene (DPH) in solution: A combined experimental and theoretical study.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

A robust cd-based coordination polymer with high sensitivity for fluorescent detection of cefixime in environmental water and milk samples.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Spectroscopic interplay of Co(II) and Pb(II) Salamo complexes: From coordination-induced electronic modulation to antibacterial activity.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

関連する実験動画

ラテックス・グローブからの空気中の抗原.

関連する概念動画

Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Interchromophoric excitonic coupling controls phosphorescence in thermomorphs of a carbazole dimer.

Glycogen-dependent demixing of frog egg cytoplasm at increased crowding.

Preferential formation of Nω-(carboxyethyl)arginine from methylglyoxal and its accumulation in human lens proteins.

Revisiting the spectroscopic role of the s-cis rotamer of 1,6-diphenyl-1,3,5-hexatriene (DPH) in solution: A combined experimental and theoretical study.

A robust cd-based coordination polymer with high sensitivity for fluorescent detection of cefixime in environmental water and milk samples.

Spectroscopic interplay of Co(II) and Pb(II) Salamo complexes: From coordination-induced electronic modulation to antibacterial activity.

関連する実験動画

ラテックス・グローブからの空気中の抗原.

関連する概念動画

関連記事